San Francisco in Talks With Vanderbilt for Downtown Campus
The negotiations, which were reported earlier on Monday by the San Francisco Chronicle, are part of a longtime plan by the city to fill downtown vacancies with university campuses. For Vanderbilt, San Francisco would provide another outpost as it continues to expand beyond its home campus in Nashville.
'We recognize the long-term global leadership of San Francisco and its ever-growing potential, defined by a vibrant culture, dynamic innovation ecosystem and the talent drawn to its leading technology companies and top-caliber arts and cultural institutions,' John O'Brien, a spokesperson for the university, said in a statement.
Lurie and Vanderbilt declined to comment on the progress of the negotiations or provide details about the potential school.
A new satellite campus could draw more economic activity to San Francisco's urban core, which has been slower to recover from pandemic closures than other cities. London Breed, Lurie's predecessor, proposed establishing a branch of a historically Black university downtown as part of an initiative to reinvigorate the area and draw more residents.
Bringing a Vanderbilt campus to San Francisco 'would bring new energy and foot traffic downtown, and we will continue working to make that happen,' Lurie said in a statement.
Vanderbilt has been on an expansion streak, announcing plans last year to build hubs in New York City and Florida. In September, the university said it would enter a lease with a seminary to establish a 13-building campus in Manhattan's Chelsea neighborhood. A month earlier, the school proposed a $520 million expansion into West Palm Beach, Florida.
Vanderbilt wouldn't be the first elite school to branch out to San Francisco. The Wharton School at the University of Pennsylvania established a presence there in 2001, hosting its first cohort of MBA students.
--With assistance from Janet Lorin.
(Adds Wharton School in final paragraph)
More stories like this are available on bloomberg.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mint
12 minutes ago
- Mint
Vertex Falls After FDA Doubts Broad Use of Chronic Pain Drug
(Bloomberg) -- Vertex Pharmaceuticals Inc. fell after an experimental pain drug failed to benefit patients after surgery and US regulators said they didn't see a path forward for broad use of its pill in treating a chronic pain condition. Vertex has been trying to diversify beyond its core business of cystic fibrosis treatments. A key part of that strategy has been its new non-opioid pain drug, Journavx, which got US regulatory clearance in January. It was the first new type of painkiller to reach the US market in more than two decades. Shares of Vertex Pharmaceuticals fell as much as 14% in premarket trading on Tuesday. The stock is up 17% since the start of the year through Monday's close. The company is also developing the pill, a safer alternative to addictive opioids, for chronic pain caused by nerve damage. US Food and Drug Administration staff members reviewing a study of the drug said they didn't see a path forward for widespread use in the condition at this time, Vertex said in a statement disclosing its second-quarter earnings results. The drugmaker also has been studying other drugs in its pipeline to see if they have better efficacy than Journavx. The experimental pain drug VX-993 failed in a mid-stage study for treating acute pain, and Vertex halted its development as a standalone therapy for the condition, it said in a separate statement. The setback at the FDA and mid-stage trial failure 'should cause a rethink of the overall opportunity and risk profile for the pain franchise,' RBC Capital Markets analyst Brian Abrahams said in a note. The drugmaker said it would conduct a second trial of Journavx in patients with diabetic peripheral neuropathy, and won't start a final study that was being planned in a different condition. Diabetic peripheral neuropathy is 20% of the neuropathic pain market, Abrahams said. More than 110,000 prescriptions for the medicine have been written and filled for acute pain conditions since it became available in early March, the company said. The novel pain drug VX-993 didn't yield a statistically significant benefit for patients getting bunionectomy surgery, the company said. The failure suggests 'it may be more challenging than some expected to iterate and improve upon' Journavx, Abrahams said in a note. The FDA's stance removes the potential for Vertex to capture the broadest chronic pain market, he said. The company also reported second-quarter revenue and profit that came in ahead of analyst estimates, and reaffirmed its full-year revenue view. Chief Scientific Officer David Altshuler announced his plan to retire on Aug. 1, 2026. Mark Bunnage, the current senior vice president of global research, will take over the role on Feb. 1 as part of a transition plan, the company announced. --With assistance from Subrat Patnaik. (Updates with premarket shares in the third paragraph.) More stories like this are available on
Mint
2 hours ago
- Mint
Oil Edges Down as Traders Weigh Trumps Latest India Threat
(Bloomberg) -- Oil extended a three-day drop, as investors weighed risks to Russian supplies, with US President Donald Trump stepping up a threat to penalize India for buying Moscow's crude. Brent traded near $68 a barrel after shedding more than 6% over the previous three sessions, while West Texas Intermediate was just shy of $66. Trump said he would be 'substantially raising' the tariff on Indian exports to the US over the nation's purchases of Russian oil as part of a bid to force Moscow to agree a truce in Ukraine. New Delhi slammed the move as unjustified. Oil has been on a round trip, rising a few dollars above $70 and then falling back, as traders try to gauge whether Trump will follow through on his threats to punish Russian oil buyers. Crude prices have held up in recent months in part because inventory builds haven't appeared near vital pricing points and instead have been concentrated on China. 'It's pretty hard to predict what's going to happen between Russian sanctions, Iranian sanctions, Chinese storage, and then the underlying fundamentals of the oil markets,' BP Plc Chief Executive Officer Murray Auchincloss said in a Bloomberg Television interview. 'It's sanctions on Russia, sanctions on Iran, Chinese behavior on storage. Those are the things that'll drive oil market prices moving forward.' The US president's latest warning to India came ahead of his Aug. 8 deadline for Russia to reach a truce with Ukraine. US Special Envoy Steve Witkoff is expected to visit Moscow on Wednesday, Tass reported. India emerged as the biggest buyer of Russian seaborne exports of crude following Russia's invasion of Ukraine in 2022, soaking up discounted barrels shunned by western nations and ramping up purchases from almost zero to about one-third of imports. China is also a major taker of Moscow's oil. The comments came just days after the Organization of the Petroleum Exporting Countries and its allies announced another bumper output hike, fully completing the return of one layer of supply cuts. The group will now have to decide whether to return more barrels in the coming months, despite forecasts of oversupply into the end of the year. Against that backdrop, both BP and Saudi Aramco said Tuesday that oil demand is holding up well so far. Aramco's Chief Executive Officer Amin Nasser said US tariffs are having a limited impact on oil demand, while consumption is being supported by gasoline and jet fuel use in the US and China. To get Bloomberg's Energy Daily newsletter in your inbox, click here. --With assistance from Kriti Gupta and Oliver Crook. More stories like this are available on
&w=3840&q=100)
Business Standard
2 hours ago
- Business Standard
How Brazil, US, and EU tackled ethanol blends before India's E20 push
India's push to adopt E20 petrol, 20 per cent ethanol blended with petrol—, marks its entry into a global club moving toward cleaner automotive fuels. But India's experiment is not happening in isolation: countries like Brazil, the United States, and many European nations have already adopted this. Since 2023, India has been introducing E20 petrol at select fuel stations, aiming for 80 per cent of the petrol market to operate on E20 by 2025. The government argues the move will both cut oil imports and lower pollution. On July 24, Petroleum and Natural Gas Minister Hardeep Singh Puri said that blending ethanol with petrol has boosted India's energy security and delivered environmental benefits. While available data largely supports these assertions, concerns are being raised in other sectors. Automobile makers have pointed to potential technical issues and reduced fuel efficiency, particularly with higher ethanol blends such as E20. Consumer advocacy groups have also expressed reservations about the possibility of higher fuel costs translating to fewer kilometres per litre. Brazil: Early mover, mainstream success • Brazil pioneered large-scale ethanol blending in the 1970s, responding to the global oil crisis. Backed by state price incentives, blending mandates, tax breaks, and communications campaigns, Brazil's government made ethanol both economically attractive and easy for drivers to understand. • According to Bloomberg reports from 2023 and 2025, flex-fuel vehicles dominate the Brazilian market, constituting approximately 84.5 per cent of all vehicle sales as of 2025. • While public acceptance remained high, reliance on sugarcane for ethanol brought mixed environmental results, including concerns about land-use and biodiversity. United States: Broad adoption • The US mainstreamed E10 (10 per cent ethanol) under its Renewable Fuel Standard from 2005, with corn as the primary ethanol source. • E10, a blend of 10 per cent ethanol and 90 per cent gasoline, is widely available at most fuel stations across the country. Over 4,200 public stations in 43 states offer E85 or flex fuel, which contains between 51 per cent and 83 per cent ethanol, varying by region and season. • By 2023, more than 3,000 stations across 31 states were selling E15. Many fuel stations also provide several ethanol blend options at a single location, typically using blender pumps. Europe: Sustainability and caution over speed • Europe's blend rollouts have focused more on lifecycle emissions and consumer protection. • Countries like Austria and Belgium have adopted E10 fuel, while nations such as Germany, Finland, and France offer consumers the choice between E10 and E5 at fuel stations. • Uptake has been slowed by worries about engine safety, strong consumer protection laws, and rigorous labelling. Even with regulatory backing, consumer scepticism and patchy pump infrastructure mean several countries still lag behind, and E5 fuel remains widespread. Numbers game: Who is using what • Brazil: Flex-fuel cars are over 85 per cent of new vehicle sales • US: Over 95 per cent of petrol is E10; E15 present at only about 10 per cent of stations • EU: E10 is standard in France, Germany, and the UK, but E5 remains common elsewhere • India: Targets achieving 20 per cent ethanol blending (E20) in 80 per cent of the petrol market by 2025-26 What India can learn India faces a critical transition -- older vehicles still dominate the market, and awareness about E20 is patchy, especially outside big cities. Some stations lack clear labels, raising concerns similar to those faced in the US about misfuelling and consumer confusion. Here's what India can learn from • Brazil: The importance of consumer-ready vehicles and visible pricing advantage. • US: Risks related to labelling, engine compatibility, and industry opposition. • EU: The need for sustainability criteria and a slow, phased rollout with robust consumer safeguards. India started blending ethanol in the early 2000s with E5, steadily ramping up policy via the 2018 National Policy on Biofuels and the 2021 Ethanol Roadmap. It reached E10 ahead of schedule in 2022, and E20 is rolling out since 2023. The Bureau of Indian Standards and Ministry of Road Transport and Highways are updating technical rules for fuel, vehicles, and pumps. As India prepares to make E20 the default grade by April 2025, learning from global experience will be vital for consumer trust, vehicle safety, and rural livelihood gains from a local bioethanol industry.
